Kazia Therapeutics KZIA
NASDAQ KZIA
$8.21 +0.03 (+0.37%)
As of: Oct 22, 2026 · 12:01 PM EDT

Kazia Therapeutics (KZIA) EBIT Margin (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported EBIT Margin of -53447.62% for the year ended Jun 30, 2025, down 52275.65 percentage points from -1171.97% a year earlier.

Analysis

Kazia Therapeutics (KZIA) EBIT Margin (2009 - 2013) Analysis & Trends

Dating back to the year ended Jun 30, 2009, Kazia Therapeutics' EBIT Margin record includes 13 years.

  • EBIT Margin has a four-year change of -53388.97 percentage points (years ended Jun 2021 to Jun 2025).
  • The figure for the year ended Jun 30, 2025 ranks as the lowest annual EBIT Margin in data going back to the year ended Jun 30, 2009.
  • According to Business Quant data, EBIT Margin came in at -1171.97% in the year ended Jun 30, 2024 and -58.64% in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,170.64 Bn 1,139.22 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 640.54 Bn 559.06 Bn 17.26 Bn 28.21%
3 AbbVie 501.78 Bn 474.89 Bn 12.70 Bn 37.86%
4 Merck 374.95 Bn 329.32 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.43 Bn 266.42 Bn 11.24 Bn 32.97%
6 Astrazeneca 268.31 Bn 241.99 Bn 12.86 Bn 20.57%
7 Amgen 242.70 Bn 198.10 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.64 Bn 167.84 Bn 6.22 Bn -133.21%
9 Pfizer 172.34 Bn 118.98 Bn 10.94 Bn 28.37%
10 Kazia Therapeutics 605,189.81 -51.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 -167.18%
Dec 31, 2012 -761.91%
Dec 31, 2011 1,187.45%
Dec 31, 2010 891.05%
Dec 31, 2009 108.11%
API Access

Kazia Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY